Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

41 results about "Antiviral gene" patented technology

Scientists Discover How Antiviral Gene Works. It's been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying.

Tobacco mosaic virus gene fragment for efficiently producing siRNA, attenuated vaccine, preparation method and application thereof

The invention relates to the field of plant antiviral genetic engineering, and discloses a tobacco mosaic virus gene fragment for efficiently producing siRNA, an attenuated vaccine, a preparation method and application thereof. The tobacco mosaic virus gene fragment that efficiently produces siRNA includes at least one of a TMV1 fragment, a TMV2 fragment and a TMV3 fragment. The nucleotide sequences of the TMV1 fragment, the TMV2 fragment and the TMV3 fragment are shown as Seq ID No. 13, Seq ID No. 14 and Seq ID No. 15, respectively. The gene fragment can produce siRNA efficiently after beinginoculated with parasitic plants. The attenuated vaccine is based on the attenuated mutant of TVBMV. The attenuated mutant of TVBMV is embedded with an effective gene fragment that can induce cross protection against tobacco mosaic virus. The effective gene fragment comprises the tobacco mosaic virus gene fragment capable of producing siRNA. The attenuated vaccine against tobacco mosaic virus hasstable effects, can play an effective cross-protection role, significantly reduces the damage of plants infected with tobacco mosaic virus virulent strains, delays the onset of plants, and greatly reduces losses.
Owner:中国烟草总公司黑龙江省公司烟草科学研究所 +1

Fluorescence quantitative kit for antiviral gene Mxa and detecting method thereof

The invention relates to a reagent box, in particular to an anti-virus gene MxA fluorescence quantitative reagent box and the detection method thereof. The reagent box comprises MxA, housekeeping gene GAPDH amplification primers, DNA polymerase a probe used for PCR reaction, and one or more kind(s) of buffer solution thereof. The detection method comprises the following steps: firstly, peripheral blood mononuclear cell PBMC is gathered; secondly, PBMC cells with interferon are irritated; thirdly, a TA clone including MxA and housekeeping gene GAPDH target gene fragments is established; fourthly, real-time fluorescence PCR is adopted to detect the inducible expression of MxA mRNA; fiftyly, the Ct value of samples is judged according to the standard curve and the domain value. The anti-virus gene MxA fluorescence quantitative reagent box and the detection method of the invention have the advantages that after adopting the irritation of the peripheral blood interferon, the expression of the MxA can reflect the therapeutic effect of patients with interferon after being treated, thus patients and doctors have vital significance to select the interferon treatment, and the waste of medical resources is avoided.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Recombinant HSV (Herpes Simplex Virus) amplicon vector and application thereof

ActiveCN102212559BAvoid silencingAvoid pollutionFermentationGenetic engineeringDiseaseBacterial replication
The invention relates to a recombinant HSV (Herpes Simplex Virus) amplicon vector and application thereof. By using two replication deficient adenoviruses respectively carrying Cre and an operative linked component loxP-HSVoriS-pac-transgenic expression box-loxP, a novel HSV amplicon vector is recombined in a coinfection cell. Being different from the traditional HSV amplicon vector taking bacterial plasmids as a skeleton, the amplicon vector does not contain a bacteria copying sequence (colEorigin) and a resistance gene component and only contains oriS of HSV, a pac sequence and a transgenic expression box. The recombinant HSV amplicon vector disclosed by the invention is used for preparing a novel HSV amplicon vector, which does not contain the bacterial gene component and is used for various types of transgenic researches and tumour gene treatments, and preparing an adenovirus treatment preparation for specific anti-HSV virus and related diseases. The HSV amplicon vector recombined by the replication deficient adenovirus of the preparation in cells replicates itself by using infected wild HSV virus and competitively inhibits or permanently expresses the antiviral genes so as to inhibit replication of wild HSV virus. Therefore, the recombinant HSV amplicon vector can be used for resisting HSV infection and treating related diseases thereof.
Owner:ZHENGZHOU VIRIGE BIOTECH

Antivirus plant expression vector constructed by utilizing pre-miR159a and application thereof

The invention relates to clone, reconstruction and transformation of a precursor (pre-miR159a) of arabidopsis thaliana microRNA159a and antivirus analysis of a transgenic plant and belongs to the techThe invention relates to clone, reconstruction and transformation of a precursor (pre-miR159a) of arabidopsis thaliana microRNA159a and antivirus analysis of a transgenic plant and belongs to the technical field of molecular biology and biology. The technology clones a nucleotide sequence of pre-miR159a from the arabidopsis thaliana and carries out site-directed mutagenesis on the sequence producinical field of molecular biology and biology. The technology clones a nucleotide sequence of pre-miR159a from the arabidopsis thaliana and carries out site-directed mutagenesis on the sequence producing mature miR159a. 126kDa protein of tobacco mosaic virus, 25kDa protein of potato virus X and HC-Pro protein of potato virus Y are subjected to genetic mutation to obtain three sections of the mutating mature miR159a. 126kDa protein of tobacco mosaic virus, 25kDa protein of potato virus X and HC-Pro protein of potato virus Y are subjected to genetic mutation to obtain three sections of the mutation sequences. The three sections of the sequences are in series to construct the plant expression vector; and an agrobacterium-mediated method is adopted to transform nicotiana benthamiana to obtain ton sequences. The three sections of the sequences are in series to construct the plant expression vector; and an agrobacterium-mediated method is adopted to transform nicotiana benthamiana to obtain transgenic tobacco. The transgenic plant has high disease resistance on three viruses. The antivirus strategy has the advantages of strong disease resistance, durable disease resistance, biological safransgenic tobacco. The transgenic plant has high disease resistance on three viruses. The antivirus strategy has the advantages of strong disease resistance, durable disease resistance, biological safety and the like and has wide application prospect in the breeding field of plant antivirus genetic engineering.ety and the like and has wide application prospect in the breeding field of plant antivirus genetic engineering.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Tobacco mosaic virus gene fragment, attenuated vaccine, preparation method and application thereof for efficient production of siRNA

The invention relates to the field of plant anti-virus genetic engineering, and discloses a tobacco mosaic virus gene fragment for efficiently producing siRNA, an attenuated vaccine, a preparation method and an application thereof. The tobacco mosaic virus gene fragments that efficiently produce siRNA include at least one of the TMV1 fragment, the TMV2 fragment and the TMV3 fragment, and the nucleotide sequences of the TMV1 fragment, the TMV2 fragment and the TMV3 fragment are respectively Seq ID No.13, Seq ID No. 14. As shown in Seq ID No.15, the gene fragment can efficiently produce siRNA after being inoculated with parasitic plants. The attenuated vaccine is based on the attenuated TVBMV mutant, and the TVBMV attenuated mutant is embedded with an effective gene fragment that can induce cross-protection against tobacco mosaic virus, and the effective gene fragment includes a tobacco mosaic virus gene fragment that can produce siRNA. The anti-tobacco mosaic virus attenuated vaccine of the present invention has a stable effect, can play an effective cross-protection role, significantly reduces the damage of plants infected by strong tobacco mosaic virus strains, delays the onset of plants, and greatly reduces losses.
Owner:中国烟草总公司黑龙江省公司烟草科学研究所 +1

Ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners, and preparation method and application thereof

InactiveCN101838654AScreening Technology ImprovementsConvenient researchPeptide/protein ingredientsAntiviralsCeratopteris pteridoidesDisease
The invention discloses a ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners, and a preparation method and application thereof. The preparation method comprises the following steps: 1, extracting total DNA by using an improved CTAB method, and preserving; 2, amplifying the intermediate segment of the ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners; 3, amplifying 5' flanking sequence of the ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners; 4, amplifying 3' flanking sequence of the ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners; and 5, recycling and cloning the PCR product: recycling the intermediate segment of the target gene, and 5' and3' flanking sequence segments, transforming, culturing and selecting white colonies; and 6, judging the clone, measuring the sequence and splicing. The gene can be used for regulation and control on expression of potential antivirus genes in plant research, carrying out research into plant antivirus gene engineering, and further establishes a ceratopteris pteridoides CVNH protein preparation system, thereby finally realizing large-scale industrial production.
Owner:WUHAN BOTANICAL GARDEN CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products